HB 45

  • Pennsylvania House Bill
  • 2017-2018 Regular Session
  • Introduced in House
  • Passed House Apr 18, 2017
  • Passed Senate Oct 02, 2017
  • Signed by Governor Oct 11, 2017

An Act providing for the use of investigational drugs, biological products and medical devices by terminally ill patients.

Abstract

Bill Sponsors (44)

V. Brown

     
Cosponsor

D. Costa

     
Cosponsor

A. Harris

     
Cosponsor

James

     
Cosponsor

W. Keller

     
Cosponsor

O'Brien

     
Cosponsor

Ward

     
Cosponsor

Deluca

     
Cosponsor

D. Miller

     
Cosponsor

Votes


Actions


Oct 11, 2017

House

Approved by the Governor

Oct 05, 2017

House

Presented to the Governor

Oct 04, 2017

House

Signed in House

House

House concurred in Senate amendments

House

Signed in Senate

Oct 03, 2017

House

Re-reported on concurrence, as committed

House

Referred to RULES

Oct 02, 2017

Senate

Third consideration and final passage

Jul 26, 2017

Senate

Removed from table

Jul 17, 2017

Senate

Laid on the table (Pursuant to Senate Rule 9)

Jun 30, 2017

Senate

Second consideration

Jun 21, 2017

Senate

First consideration

Senate

PN 2108 Reported as amended

Apr 20, 2017

Senate

Referred to HEALTH AND HUMAN SERVICES

Apr 18, 2017

House

Third consideration and final passage

House

Re-reported as committed

Apr 05, 2017

House

Re-committed to APPROPRIATIONS

House

PN 1264 Second consideration, with amendments

Apr 04, 2017

House

Removed from table

Mar 22, 2017

House

PN 1051 Reported as amended

House

Laid on the table

House

First consideration

Jan 23, 2017

House

PN 0051 Referred to HUMAN SERVICES

Bill Text

Bill Text Versions Format
Printer's No. 0051 HTML PDF MSWORD HTML
Printer's No. 1051 HTML PDF MSWORD HTML
Printer's No. 1264 HTML PDF MSWORD HTML PDF
Printer's No. 2108 HTML PDF MSWORD PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Pennsylvania General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.